DENVER, CO — The introduction of HB1260, The Drug Price Transparency Act of 2018, brings Coloradans one step closer to lowering drug prices. The legislation is strongly endorsed by Patients For Affordable Drugs NOW, a bipartisan national patient organization focused on policies to lower drug prices. P4ADNOW announced plans to educate, activate, and mobilize Colorado patients in support of the bill.
The group will create online tools that help patients contact elected officials in support of the bill, and it will amplify the voices of Coloradans struggling under high drug prices to make elected officials see the heavy toll of high-priced drugs.
Retired nurse Margaret Wright-Mueller is among those Coloradans hurting under skyrocketing drug costs and rooting for the transparency bill.
Wright-Mueller is one of more than 300 Colorado patients who have shared stories with Patients For Affordable Drugs NOW.
Require health insurance providers to report to the Insurance Commissioner a list of their most expensive drugs.
Require manufacturers to report a range of information about drugs with a wholesale cost of $40 when they increase in price by more than 10% over 24 months.
Require the Insurance Commissioner to make this information public.
This move toward transparency can help further discussions over how we can address prices in the long term.
Patients For Affordable Drugs NOW does not accept donations from organizations that profit from the development and distribution of prescription drugs.